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ADJUSTMENT FOR SUSPECTED MISCLASSIFIED 
SMOKING DATA IN AN HISTORICAL COHORT STUDY OF 
WORKERS EXPOSED TO ACRYLONITRILE  
Sarah Downing Zimmerman, MS 
University of Pittsburgh, 2013 
Objectives: To examine the association between exposure to acrylonitrile (AN) and lung cancer
mortality after properly addressing misclassification and possible positive confounding of smoking 
history. 
Methods: Subjects were 992 white males who were employed for three or more months between
1960 and 1996 at an AN chemical plant in Lima, OH. There were 15 identified cases of lung cancer 
deaths. Smoking histories were obtained for 90.3% of the cohort and 54.2% of the cohort were 
identified as having “ever smoked”.  Though there were few “unknown” smoking histories, the 
smoking variable was determined to be misclassified as the RR for having ever smoked related to 
lung cancer was only 1.08 (95% CI=0.26, 6.18). We addressed potential confounding by smoking 
in the presence of suspected misclassified smoking data by determining if a reasonable adjustment 
of the available smoking data would change the risk levels of lung cancer in the original Lima 
cohort and the relationship between AN exposure and lung cancer using Monte Carlo simulation 
and bias adjustment. 
Conclusions: After running Monte Carlo simulation, we found that the mean RR of lung cancer
mortality given differing levels of AN exposure decreased after adjusting for the simulated smoking 
data. However, the results from the bias adjustment must be interpreted with caution as the analysis 
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was limited by the number of lung cancer cases. In this cohort, we concluded that smoking 
positively confounded the relationship between AN exposure and lung cancer mortality. 
Public Health Relevance:  Properly adjusting for smoking history in studies of lung cancer is 
critical of the validity of the study results. As seen in this study, smoking habits impact the risk of 
certain health outcomes. Researchers must attempt to address the potential confounding by smoking 
whenever possible. 
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1.0    INTRODUCTION 
 
1.1    BACKGROUND AND RATIONALE 
 
Acrylonitrile (AN) is a chemical used in the production of many plastics, synthetic fibers and 
rubbers, and previous experimental studies have shown AN to be carcinogenic in animals. Excess 
exposure to AN in rats has resulted in certain types of cancer (astrocytomas), occurring in the brain 
and spinal cord, and tumors of the Zymbal gland, forestomach, stomach and mammary gland 
(Strother et al., 1998).  Due to the prevalence of AN in manufacturing, many studies focus on 
human exposure to the chemical in occupational settings, and researchers are interested in 
determining if AN is potentially carcinogenic to humans. To date, epidemiologic studies have 
provided inconclusive evidence to support a claim that AN is carcinogenic to humans. AN is 
currently labeled as a “possible” (Group 2B) carcinogen by the International Agency for Research 
on Cancer (IARC, 1999). 
 
There are four main occupational cohort mortality studies that focus on the health effects of AN. 
The National Cancer Institute (NCI) performed the largest study to date which analyzed the 
relationship between the manufacture and use of AN and mortality rates among employees in eight 
facilities (Blair et al., 1998). In this study, researchers attempted to find a relationship between 
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varying levels of exposure to the chemical and changes in mortality rate of the workers. They 
concluded that the exposure levels in the facilities did not create a significant increase in relative 
risk of cancer deaths, but they did notice an “excess of lung cancer in the highest quintile of 
cumulative exposure.” Similar analyses were performed in other cohort studies, for example in 
South Carolina (DuPont cohort- Symons et al., 2008), the UK (Benn et al., 1998), and the 
Netherlands (Swaen et al., 1998). These studies reported slight elevations in risk for several types of 
cancer mortality, including lung cancer, but found no statistically significant relationship between 
exposure to AN and the risk of lung cancer mortality.  
 
Researchers would like to conduct a full evaluation of this increased risk for lung cancer, however 
they are limited by the absence or misclassification of smoking data. In all studies of lung cancer, 
one must take into account the effects of smoking on the occurrence of lung cancer as there is a 
well-known relationship between these factors. However, in the UK, Dutch, and DuPont analyses 
mentioned above, smoking data are missing, and it is possibly misclassified in the NCI study. As 
such, one cannot draw full conclusions about the association between AN exposure and lung cancer 
in these studies. 
 
In 1995, the University of Pittsburgh’s Center for Occupational Biostatistics and Epidemiology 
(COBE) was commissioned by BP Chemicals, Inc. (BPC) to perform an updated and extended 
investigation of mortality patterns with an emphasis on cancer mortality in relation to AN exposure 
within their chemical plant located in Lima, OH (Marsh et al. 1999), which was one of the eight 
plants studied in the NCI cohort study. At BPC’s request, COBE updated the mortality and work 
histories of employees from this plant to include data on those employees who worked at the plant 
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for at least three months between 1960 and 1996. The study gathered data on 992 white males who 
worked in the plant during this time period. Of these 992 workers, 15 of them died from lung 
cancer. In this update, smoking histories were also provided to enable an evaluation of the 
relationships among AN exposure, lung cancer mortality, and smoking history.  
 
In the Marsh et al. publication (1999), there was limited evidence of an exposure-response trend 
between AN exposure and lung cancer after adjusting for time since first employment. In the lowest 
(>0 - 4.9 ppm), middle (5.0 - 11.9 ppm) and highest (12.0+ ppm) categories of average intensity of 
AN exposure, the relative risk (RRs) and associated confidence intervals were 1.18 (95% CI=0.16, 
6.84), 1.46 (95% CI=0.22, 7.29) and 2.91 (95% CI=0.46, 14.13) respectively. They concluded that, 
although the exposure-response analysis showed monotonically increasing RRs for lung cancer 
given AN exposure, this trend was not statistically significant. Accurately accounting for smoking 
history in the evaluation of the relationship between AN exposure and lung cancer is a necessary 
step in evaluating an exposure-response trend.  
 
In the Marsh et al. study (1999), however, the final exposure-response results were not adjusted for 
smoking histories of the workers because the RR for lung cancer mortality related to smoking 
history was inordinately low. This RR was 1.08 with 95% confidence interval (0.28, 6.18). It is well 
known (as discussed later) that smoking is a major risk factor of lung cancer, and this relationship 
was not evident in the smoking data from the 1999 study. As the smoking variable was not a 
statistically significant predictor of lung cancer mortality, the data was considered to be highly 
misclassified, and thus smoking information was not included in the analysis. This thesis will 
address the issue of possible smoking misclassification in the 1999 study. 
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1.2    STATEMENT OF THE PROBLEM 
 
In this thesis, using Monte Carlo simulation and bias adjustment, I will address potential 
confounding by smoking in the presence of suspected misclassified smoking data by determining if 
a reasonable adjustment of the available smoking data changes the risk levels of lung cancer in the 
original Lima cohort and the relationship between AN exposure and lung cancer. This will provide 
a more valid assessment of the association between AN exposure, lung cancer mortality, and 
smoking history. The focus of this thesis will use the Lima, OH cohort updated by COBE (Marsh et 
al., 1999) with the study period January 1, 1960 to December 31, 1996. 
 
1.3    RELATIONSHIP BETWEEN SMOKING AND LUNG CANCER 
 
Smoking history for the workers in the original Lima cohort was determined by a voluntary mail-in 
survey issued by BP. Also, medical records were examined by the original researchers to obtain 
more information on lifetime smoking history.  The relationship between smoking history and AN 
exposure is displayed in Table 1. The first column groups workers based on their cumulative 
exposure to acrylonitrile over the course of their entire employment at the plant. For example, 
among of all workers with a cumulative exposure over 110 parts per million per year (ppm-years), 
three workers died of lung cancer, and 61 of the workers in this category admitted to having ever 
smoked (which accounts for 80.3% of all people in this category). Also, 13 workers with exposure 
rates above 110 ppm-years claimed to have never smoked (17.1% of the category). Cumulative 
exposure is displayed in this table (rather than duration of exposure or average exposure) to enable 
the comparison of smoking histories of those in the highest exposure levels to those unexposed to 
AN. Within the total cohort, smoking data were gathered for 90.3% of workers and 93.0% of AN 
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exposed workers. Further, 54.2% of the workers were identified as having “ever smoked”. Those 
without reported smoking histories were classified as unknown. 
 
Table 2 displays results from Marsh et al’s (1999) univariate risk estimates for smoking history, AN 
duration (Dur) of exposure, AN cumulative (Cum) exposure, and AN average intensity of exposure 
(AIE). In the row corresponding to “Smoking History”, we note that, of the 15 reported deaths due 
to lung cancer, three people claimed to have never smoked, 10 claimed to have smoked and two had 
unclassified smoking data. Here, it is shown that the univariate RRs of lung cancer mortality due to 
smoking is 1.08 with associated p-value=0.999, while the RR of those with unknown smoking data 
is 1.18. Because the RR of lung cancer mortality due to smoking history was close to 1.00 for both 
ever and unknown smokers in the original study, smoking history was not a significant main effect 
of lung cancer mortality, and was thus not included in the final statistical model developed by 
Marsh et al. (1999). Further explanation of relative risk regression is in Section 2.1. 
 
Table 3 shows a summary of the relative risk regression analysis for lung cancer mortality adjusted 
for time since first employment as reported by Marsh et al. in 1999. This thesis will investigate 
whether reassigning smoking history data through simulation will change the exposure-response 
trend reported by Marsh et al. by comparing the adjusted data to the data displayed in Table 3.  
 
Earlier studies have shown that the risk of lung cancer increases 11-fold (Higgins and Wynder, 
1988) among those who have ever smoked and reported the odds ratio to be 35.5 (Samet, 1993) 
among heavy smokers compared to non-smokers.  The US Surgeon General’s report (2006) shows 
a comparison of lung cancer standardized mortality ratios (SMR) between smokers and 
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nonsmokers. The reported SMRs for smokers ranged from 2.03 to 14.20 in a Japanese study (Loeb 
et al., 1984) and a Canadian Veterans study (Loeb et al., 1984), respectively. The American Cancer 
Society (Loeb et al., 1984) reported the lung cancer SMR to be as high as 10.73 in smokers 
compared to nonsmokers.  
 
Given the RRs for lung cancer mortality due to smoking observed in the literature, the “inordinately 
low” RR mentioned above of 1.08 reported by Marsh et al. (1999) strongly suggests smoking was 
misclassified among members of this cohort.  In the first part of this thesis, we attempted to 
determine if adjusting the data for smoking and then including it in the final analysis would change 
the results (thereby showing that misclassification of smoking data has a strong impact on the 
outcome of the study). This was done by randomly reassigning a percentage of workers labeled as 
“non-smokers” to “smokers” repeatedly via a Monte Carlo process, and repeatedly analyzing the 
results. This process generated a more realistic RR between the smoking data and the lung cancer 
mortality cases. In the second part of this thesis, we attempted to remove any bias related to 
smoking history from the final RR of lung cancer mortality related to AN exposure using 
Richardson’s method (2010) described in more detail later. 
 
1.4    CONFOUNDING BY SMOKING 
 
Confounding can occur when a third variable (here, smoking history), which is not in the causal 
pathway between the exposure and health outcome (here, AN exposure and lung cancer), is related 
to both factors.  The first step is to determine if the potential confounder is a statistically significant 
risk factor for the health outcome. If it is a risk factor, then the variable (smoking history) has the 
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potential to confound the exposure-response relationship if it is also related to the exposure variable 
(AN exposure). It is possible that the limited evidence of a relationship between AN exposure and 
lung cancer in the NCI study (Blair et al., 1998) and the Lima cohort study (Marsh et al., 1999) was 
due, at least in part, to a misclassification of smoking history among the workers, and  a more 
accurate assessment of the association (or lack thereof) will result after accounting for the potential 
confounding by smoking history. 
 
A well-known example of confounding occurred in a classic study in which researchers were 
attempting to find causes of lung cancer. In this study (Marsh et al., 1988), researchers noticed that 
many of the participants who had lung cancer also frequented bars. From this information, they 
drew the conclusion that alcohol increased the risk for lung cancer. However, the researchers failed 
to take into account that these participants were inhaling a large amount of cigarette smoke while at 
the bar. This is an example where the confounding variable (smoking) affected the conclusion 
relating the risk factor (alcohol) and health outcome (lung cancer). Specifically, this is an example 
of positive confounding as the relationship between alcohol consumption and lung cancer was 
artificially increased by the confounding effects of smoking. Negative confounding occurs when the 
confounding variable masks the association between the risk factor and health outcome.  
 
If smoking is more prevalent among workers with higher exposure rates and less prevalent among 
those with lower rates, positive confounding by smoking is likely to have occurred between these 
variables.  In the Lima cohort study (Marsh et al. 1999), those workers who experienced a higher 
cumulative exposure to AN were more likely to report having ever smoked. This relationship is 
evident in Table 1; as AN exposure increases, the number of those identified as “ever smoked” is 
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larger than “never smoked”. Thus, positive confounding by smoking is a possibility in this study. In 
this thesis, we attempted to identify and account for the extent to which smoking was positively 
confounding the relationship between AN exposure and lung cancer mortality. 
 
As shown in Table 2, there was a monotonically increasing exposure-response trend for AN 
exposure and lung cancer mortality, and a sufficient amount of smoking data is present to analyze 
the effect of confounding on the results. We were able to adjust the smoking data through 
simulation and investigate the resulting effect on the exposure-response relationship. 
 
 
2.0    PROPOSED METHODS FOR THESIS 
 
2.1    OVERVIEW OF METHODS 
 
Several approaches are available for adjusting an exposure-response analysis for a potential 
confounding variable. This thesis will implement and compare two techniques to account for the 
potential confounding effect of smoking on the relationship between AN exposure and lung cancer 
mortality. 
 
The first technique used to adjust for confounding is a sensitivity analysis using the Monte Carlo 
(MC) method. The MC method is a general procedure that is used to run simulations many times. In 
this thesis, we will simulate the problematic variable (i.e. smoking history) by random reassignment 
of the “never smoked” label to “ever smoked”. We will then perform regression analysis using the 
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new variable and repeat this combination using the simulated variable many times. Using the MC 
method, we can analyze the sensitivity of the RRs and thereby answering the question “how much 
did these RRs change as a proportion of the smoking data was changed from never smoked to ever 
smoked”?  
 
Steenland and Greenland used a very similar method in their publication, “Sensitivity Analysis of 
an Unmeasured Confounder” (2004), where the authors used and compared two different methods 
to adjust for confounding by smoking on lung cancer risk: MC sensitivity analysis and Bayesian 
bias analysis. Steenland and Greenland concluded that the two methods yielded similar results and 
that these types of analyses “should be more widely adopted by epidemiologists” (2004). Also, a 
similar approach was used by Cunningham (2005) in his unpublished thesis to adjust for missing 
smoking data in the NCI case-cohort study. Though similar in methodology, this thesis will address 
misclassification rather than missing data in smoking history using the MC approach.  
 
The second approach, developed by Richardson (2010), is used if smoking history is too difficult to 
obtain or if there exists a large proportion of missing data. This is a common issue, as it is rare to 
accumulate accurate smoking data in a cohort study. Richardson proposed a method in which one 
can estimate and remove the bias of smoking from the RR of AN exposure related to lung cancer 
mortality. Richardson suggests using this method as this approach does not require smoking data or 
assumptions of the smoking variable distribution. 
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2.2   FIRST METHOD: MONTE CARLO (MC) SIMULATION 
 
The following general steps are required to incorporate the Monte Carlo (MC) approach: 
Step 1: Adjust data to achieve a realistic odds ratio (OR) for smoking and lung cancer 
similar to those shown in the Surgeon General’s Report (2010), 
Step 2: Generate risk sets using OCMAP (Marsh et al 1998), a statistical software, to help 
adjust for the effect of potential confounding due to age and time period on health 
outcome, 
Step 3: Simulate a new smoking history variable using the MC approach, 
Step 4: Run conditional logistic regression models to estimate the relative risk (RR) of 
smoking using the simulated smoking variable, 
Step 5: Compare the new RRs to the original RRs to determine if adjusting for the new 
smoking variable affects the risk of lung cancer given exposure to AN. 
 
Step 1:  Adjust Data to Achieve a More Realistic Odds Ratio 
 
According to the Surgeon General’s Report (1986, 2010), about 90% of lung cancer cases can be 
attributed to smoking. In the original Lima cohort, only around 67% of those people who died of 
lung cancer were identified as smokers according to the literature. This, along with the inordinately 
low RR for smoking and lung cancer mortality observed in the original cohort by Marsh et al. 
(1999), provides evidence that the smoking data are possibly misclassified, as a higher percentage 
of those who died of lung cancer should have also been smokers. In order to achieve a more 
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realistic percentage, the smoking data must be reclassified through simulation to reflect a higher 
smoking prevalence within lung cancer deaths.  
 
Table 4 illustrates how the odds ratio (OR) of lung cancer mortality related to smoking increases as 
the prevalence of smoking is increased. The ORs were calculated using 2x2 tables. The first row in 
the table displays the information about the original data set. In this set, 10 workers who died of 
lung cancer (cases) were identified as having ever smoked, and five of the cases were identified as 
never having smoked or had missing smoking data. Thus, about 66.7% of all cases had identified 
themselves as smokers. The OR for this scenario is presented in the fifth column, and the last 
column displays the p-value from a Fisher’s Exact Test on the null hypothesis that the OR equals 
1.00. The following rows display scenarios in which the prevalence of smoking was increased by a 
value of one each time. In other words, one case labeled as “never smoked” or “unknown” was 
reassigned to “ever smoked.” In each of these new scenarios, the smoking prevalence, OR, and p-
value were calculated. These changes were made with the purpose of adjusting the smoking 
prevalence among cases and increasing it to a more realistic value similar the one reported by the 
Surgeon General (1986, 2010). 
 
Table 4 shows that as the smoking prevalence increased within cases, the OR increased as well. As 
the prevalence approached 90.0%, the OR approached 10, which is expected as the Surgeon 
General’s report (1986, 2010) concluded that the SMR for lung cancer given smoking is around 10. 
In the final and most extreme scenario, the p-value is 0.028 indicating a statistically significant 
relationship between smoking and lung cancer mortality exists. 
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This thesis will focus on the results shown in Table 4 Scenario 4. Recall that, in order for a variable 
to cause confounding in a study, a relationship between the confounding variable and the main risk 
factor is necessary. This was shown to be the case between AN exposure and smoking in this data 
set in Table 1. Additionally, a statistically significant relationship between the confounding variable 
and the health outcome must be present. As such, we will be able to determine if smoking 
confounds the relationship between AN exposure and lung cancer death.  
 
In this analysis, we assumed that the misclassification is biased downward away from “ever 
smoking” rather than biased toward “never smoking”. One possible explanation for this 
misclassification is the self-conscious response by workers being interviewed for their medical 
records. Considering that there is a social stigma associated with being identified as a smoker, we 
will assume that many individuals would misrepresent themselves as a nonsmoker when, in reality, 
they have smoked. Workers may be unlikely to admit that they smoked when being checked by a 
health professional during regular checkups, and they may also be unwilling to admit to the 
company that they smoke due to negative responses from health insurance providers. For these 
reasons, we chose to focus on an increased prevalence of smoking within the simulation to account 
for the supposedly low amount of smoking data. 
 
Step 2: Generate Risk Sets 
 
The technique of creating a risk set is a method which matches employees who died of lung cancer 
(cases) with those who did not (controls) based on some specific criterion. A risk set was created 
for each case by matching the controls who were alive at the exact age at which the case died. That 
13 
  
is, if a case died at the age of x, then all controls who were at risk and lived to be at least x years old 
were grouped with this case. The risk set was then further matched on year of birth using caliper 
matching by only considering those controls whose birth date was within some determined range of 
the case. Thus, the case that died at x years old was matched with all controls that lived to be at 
least x, were at risk and were born within five years before or after the case’s birthday. The range of 
birthdates around each case was originally one year, but this created risk sets that were too small. 
As such, the range was increased to five years for everyone, and ten years for two cases (in order to 
create large enough risk sets). To properly analyze the data, the statistical software, OCMAP 
(Marsh et al. 1998), was used to create these risk sets for each case. By the method with which 
these risk sets were matched, it is possible that some controls appear in multiple risk sets, and some 
do not appear in any of them.  
 
Creating risk sets helps eliminate the confounding effects caused by the matched variables which, 
in this instance, are exact age and time. Age is a major factor in the onset of cancer, therefore, if 
controls and cases are matched based on exact age at death, confounding due to age should be 
reduced during the analysis within risk sets. Additionally, matching on year of birth helps eliminate 
any birth cohort effects. 
 
 Table 5 displays the counts for each risk set partitioned by smoking history information. Each row 
represents a different risk set for each case as described above. There are 15 risk sets as there were 
15 cases of lung cancer in the data set. The second column displays the number of controls matched 
with each case. The following three columns each contain a pair of numbers indicating the number 
of cases and controls in that risk set labeled at the listed level of smoking. For example, in risk set 
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one (which contains case one), 22 controls were matched, and column three shows that the case was 
identified as having ever smoked while three controls were labeled in this way. Column 4 shows 
that 16 controls in this risk set were labeled “never smoked”, and the last column indicates that 
three controls had unknown smoking data.  
 
Step 3: Simulate New Smoking Variable 
 
As mentioned above, the remainder of the analysis and simulation was conducted using adjusted 
data from Scenario 4 in Table 4 (which contained the most realistic OR for lung cancer and 
smoking prevalence among cases). In an attempt to remove confounding from the likely 
misclassification of the smoking data, we simulated new smoking history data using the statistical 
software STATA (StataCorp, 2005). The STATA code is shown in Appendix B. In these 
simulations, we reassigned some of the nonsmokers and all of those with missing smoking data to 
“ever smoked”, and then statistical analyses were performed with this new smoking information. 
The purpose of this simulation and reanalysis was to mimic the data adjustment from Table 4 on a 
large scale; we wanted to reassign the controls in a similar fashion to the cases. By comparing the 
results of the new analysis to the original results of the study, we would hopefully be able to 
determine if the smoking data confounded the association between AN exposure and lung cancer 
mortality. 
 
The details of the simulation process are as follows. First, we reassigned all of the controls who had 
unknown smoking data as “never smoked.” Then, every control labeled as “never smoked” had a 
50% probability of being randomly reassigned as “ever smoked”. Those controls that were not 
15 
  
chosen to be reassigned remained in the “never smoked” category. As for the cases, 10 of the total 
15 were identified as “ever smoked” while five cases were labeled as either “never smoked” or 
“unknown.” Similar to the controls, all cases listed as “unknown” were transformed to “never 
smoked.” Next, a total of four of the five smokers were randomly chosen and reassigned as “ever 
smoked” so that the distribution of smokers from Scenario 4 in Table 4 was reproduced. Doing so 
resulted in 14 cases labeled as “ever smoked” while one case remained as “never smoked”. This 
process of reassigning smoking histories was simulated 500 times and is referred to as “Scenario 
4A”. We chose to run this simulation 500 times as this provided enough estimates to create a stable 
mean of the RRs. Increasing the number of simulations did not change the mean RR substantially. 
This repeated simulation of data is known as a Monte Carlo simulation. 
 
To create more extreme scenarios, we reassigned the smoking data based on the AN exposure 
category. In scenario 4A, we assumed no relationship between AN exposure and smoking as the 
reassigning of nonsmokers to smokers was done randomly and did not take AN exposure into 
account. However, as discussed earlier and seen in Table 1, employees with higher levels of AN 
exposure were more likely to be classified as smokers. Therefore, we simulated scenarios 4B and 
4C to reflect this relationship. The rate at which controls were reassigned from “never smoked” to 
“ever smoked” was based on exposure category. In scenario 4B, “never smoked” controls with the 
highest average intensity exposure levels (higher than 12.0 parts per million per year) were 
reassigned as “ever smoked” 80% of the time while those with the lowest AIE levels (greater than 0 
and less than 4.9 ppm-years) were reassigned only 30% of the time. In scenario 4C, these 
probabilities were 95% and 5% respectively. Average intensity exposure was chosen to represent 
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exposure levels rather than cumulative exposure because changes in AIE exhibited the strongest 
increasing trend in RRs for lung cancer (as seen in Table 3). 
 
Step 4: Conditional Logistic Regression 
 
Once we had the simulated smoking variables for scenarios 4A, 4B, and 4C, RRs were estimated by 
running conditional logistic regression models. As the outcome is binary (case or control) and the 
observations are matched within each risk set, modeling using conditional logistic regression is 
appropriate. This model is shown here: 
  (
 ̂
   ̂
)    ̂    ̂        ̂        ̂       ̂       ̂   . 
In the Lima study,  ̂ was the probability that a worker died from lung cancer. In conditional logistic 
regression, the variables              represent which risk set a worker is assigned to through the 
matching process. Recall, all controls are matched to a case using the exact age at which the case 
died and further on the case’s year of birth. AN exposure, time since first employment, and the 
simulated smoking history variables were the explanatory variables in the model. These are 
represented by          and     respectively. The value of   (
 ̂
   ̂
), or the logit, represents the 
natural log of the probability that an individual will be a case divided by the probability that they 
will be a control given specific variables. By exponentiating the outcome of a logistic regression, 
we obtain a value of the RR. Mathematically,  
      (  (
 ̂
   ̂
)). 
In this study, the RR may be interpreted as the probability that a workers died of lung cancer 
divided by the probability that one did not given the influence of certain variables. A higher RR 
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indicates that the given conditions are more likely to result in cancer death, while an RR close to 
1.00 indicates that the risk of dying from lung cancer was not affected by variables in the model.  
 
Step 5: Analysis of Relative Risk (RR)  
 
The next step was to compare the simulated RRs to the original RRs from Marsh et al. (1999) 
(Table 3) to determine if adjusting for the new smoking variable affected the risk of lung cancer 
mortality related to AN exposure. These regression results are shown in Table 6. For comparison 
purposes, the model results in the top half of the table are taken from the original analysis by Marsh 
et al. (1999).  The first section shows the original RRs for lung cancer given the two different 
options for smoking history, along with their confidence intervals; the next section displays the RRs 
of lung cancer given the four different levels of AN exposure adjusted for time since first 
employment (as seen in Table 3) and their associated confidence intervals.  
 
The bottom half of Table 6 contains information regarding the results of the 500 simulations 
scenarios 4A, 4B, and 4C. The mean RR among all 500 simulations in scenario 4A (50% chance of 
“never smoked” controls reassigned as “ever smoked”) for those who ever smoked was 1.48 with 
standard deviation 0.43, minimum 0.48 and maximum 2.96. Similarly the mean, standard deviations 
and extreme values of RRs for the four different levels of AN exposure can also be seen in this 
section of the table. This scenario produced mean RRs nearly identical to the original AN model 
from row two. Although the RR for smoker vs. nonsmoker increased from 1.08 to a mean of 1.48, 
the RRs for the exposure categories are very similar and the same increasing trend exists. This is 
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probably due to the fact that any prior relationship between AN exposure and smoking history was 
ignored during the simulation process in scenario 4A. 
 
In scenario 4B (detailed results can be seen in following section), the mean RR for “ever smoked” 
increased to 2.48 which indicates a slightly more realistic relationship between smoking and lung 
cancer, and the mean RRs for each exposure category decreased marginally compared to the 
original RRs. Similarly, in scenario 4C, the mean RR for “ever smoked” increased to 2.92, and the 
mean RRs for the exposure categories decreased even more than in scenario 4B. 
 
This relationship between mean RRs is shown more clearly in the box plot in Figure 1. There is a 
drop in the mean RR for exposure levels from the original model and Scenario 4A to Scenario 4C. 
Notice also that the increase in mean RR for the smoking data between the scenarios mirrors the 
drop in mean RR for the highest exposure level. It is possible that such a relationship between 
increased smoking RRs and decreased exposure RRs would be more evident with a more extreme 
adjustment of the data (to create smoking RRs similar to the well-known values), but such 
adjustment is not possible with such a small number of cases. This change in RRs is evidence for 
confounding by smoking: as the risk between smoking and lung cancer mortality increases, the risk 
between AN exposure and lung cancer mortality decreases.  
 
2.3    SECOND METHOD: RICHARDSON’S METHOD 
 
In this second method, we considered a health outcome that was highly correlated with the 
confounding variable (smoking) and not correlated with acrylonitrile exposure. Richardson 
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proposed to use the occurrence of chronic obstructive pulmonary disease mortality, or COPD, as the 
new variable. As there is no known relationship between COPD and AN exposure and a strong 
relationship between COPD and smoking, Richardson determined any observed relationship 
between COPD and exposure was solely due to a relationship between exposure and smoking. This 
relationship will be used to estimate a bias which will then be removed from the RR for lung cancer 
due to exposure and thereby eliminating any confounding due to smoking. The final result will 
hopefully show the true association between AN exposure and lung cancer. 
 
The following are general steps required to incorporate Richardson’s method: 
Step 1: Using the original data, perform Richardson’s method to estimate the bias due to 
confounding by smoking, 
Step 2: Adjust the original RR for lung cancer due to AN exposure by the bias estimate, 
Step 3: Analyze the results of Richardson’s method. 
 
Step 1: Estimate Bias due to Confounding by Smoking 
 
Richardson developed a different method to estimate the bias due to confounding in his publication, 
“Occupational Exposures and Lung Cancer: Adjustment for Unmeasured Confounding by 
Smoking”. In this paper, he outlined his method for adjusting RRs to account for unmeasured or 
unknown individual smoking history. As mentioned earlier, we will investigate the relationship 
between exposure and COPD as any association between exposure and COPD should reflect the 
relationship between exposure and smoking. If we remove the effects of exposure on COPD from 
the model through subtraction, we should also be removing any association between smoking and 
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exposure in the process. This should leave us with only the association between AN exposure and 
lung cancer remaining with any confounding by smoking eliminated. 
 
Mathematically, the following is Richardson’s method. The parameter we would like to estimate is 
   which represents the log RR of lung cancer death due to AN exposure adjusted for smoking. We 
calculate this by computing: 
     (        
     )    (    ) 
where         
      represents the RR of lung cancer mortality due to AN exposure and      is the bias 
from confounding. This bias is equal to the RR of smoking given exposure which we estimate as 
the ratio of those workers exposed to AN who died of COPD to unexposed workers who died of 
COPD (denoted as       
     ). The final estimate will then be 
 ̂    (        
     )    (      
     )  
 
We have assumed that the only confounding effect in the study is due to smoking rather than other 
factors such as age or genetics. Note that Richardson said in his publication, “To be valid, such an 
interpretation requires that smoking is related to lung cancer and COPD, there is no true causal 
association between exposure and COPD, and the only uncontrolled confounder of the association 
between exposure and COPD is smoking” (2010). The first two conditions are satisfied as 
mentioned above, but we must assume that the third condition is also true to trust our results.  
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Step 2: Adjust Relative Risk (RR) Using Estimated Bias 
 
First, risk sets were created for the health outcome (lung cancer death) as described previously. 
These risk sets were used to perform a conditional logistic regression with AN exposure and 
smoking history as explanatory variables. The results of this regression analysis are displayed in the 
fourth column of Table 7. The highlighted row in this table is the adjusted RR using the original 
smoking data.  The estimate of RR = 1.035 (95% CI= (0.97, 1.11) will be used as a comparison for 
the new estimates. 
 
In the original data set, an insufficient number of COPD cases were available to properly analyze 
the data as Richardson suggests. To account for the small number of COPD cases, we also used 
mortality due to heart disease as heart disease has a high risk associated with smoking and is not 
known to be related to AN exposure. The combination of heart disease mortality and COPD 
mortality was used to create risk sets and later as the estimate for       
     . However, even when 
including heart disease as an additional cause of death, only 13 cases were observed. Thus, we 
repeated the analysis, using only cases from all non-malignant respiratory diseases (which includes 
COPD) to create the risk sets, which provided a total of only nine cases. However, there is some 
concern that some non-malignant respiratory diseases may be related to AN exposure. These 
models are shown in Table 8. Each of the rows displays one of the three models mentioned above, 
and the second column lists the number of cases in each of the situations. A univariate conditional 
logistic regression was run for each of the three new models, and the results of these are displayed 
in the fourth column in this table.  
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Step 3: Analysis of Results 
 
As shown above, using Richardson’s method, we calculated unbiased RRs using  
 ̂    (        
     )    (      
     ). 
The value of         
      is contained in the first row in Table 8. This is the result of the conditional 
logistic regression for lung cancer deaths. The other two rows contain the values of       
      (the 
estimated bias from smoking) which were used in two different applications of Richardson’s 
method. 
 
The         
            in row one of Table 8 is very close to 1.00 which indicates little relationship 
between AN exposure and lung cancer. This is consistent with the results found by Marsh et al. 
(1999). Notice the RR values for COPD and heart disease deaths in column four are very close to 
1.00. This indicates one of two things. First, it may show that there is no observable relationship 
between AN exposure and smoking, as AN exposure did not show an increased risk for COPD and 
heart disease mortality. Another possible conclusion is that heart disease mortality is not a good 
cause of death for estimating smoking bias as the relationship between smoking and heart disease 
mortality is not as strong as the relationship between smoking and COPD mortality. Therefore the 
bias due to smoking may not be properly represented. Recall, there were too few cases of COPD in 
the cohort to perform the analysis as Richardson recommends and heart disease deaths were 
included in an attempt to account for this lack of data. Unfortunately, the use of heart disease 
mortality in combination with COPD mortality may lead to an incorrect value of       
     . 
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Table 9 displays the results from the computations using Richardson’s method. Column 1 lists the 
different variables considered in the calculations. The label in parentheses indicates which values 
are used in the calculation of       
     . For example, in the first row, the RR for deaths from both 
COPD and heart disease (from row two of Table 8) is used for       
     . In the second column, the 
lower limit of the confidence interval from deaths by COPD and heart disease is used as the value 
of       
      rather than the point estimate, and the third row uses the value of the upper limit of the 
confidence interval. The second column in Table 9 displays the adjusted RR which was obtained 
through the use of Richardson’s Method for each of the variables listed in column 1 (exponentiated 
to return from a logarithmic scale to the original one). The values from column 2 were subtracted 
from the original         
            in Table 7, and this difference is shown in column 3 of Table 9. 
Finally, the 95% confidence interval for the adjusted RR is shown in the last column (computed as 
instructed in Richardson’s paper). 
 
The adjusted RR values ( ̂ ) displayed in the first three rows of column two of Table 9 are not very 
different from the         
      of 1.035 computed from the original data when smoking history is 
considered in the analysis. This means that when smoking bias is estimated by the relationship 
between COPD/heart disease mortality and AN exposure and then removed via Richardson’s 
method, there was very little effect on the RR for lung cancer mortality. This seems to indicate that 
smoking was not a confounding variable in the relationship between lung cancer death and AN 
exposure. In the last three rows, however, the RRs computed for respiratory disease deaths differ 
from 1.00 by a greater amount. When the bias for smoking is accounted for using respiratory 
disease deaths and removed using Richardson’s method, the risk of dying from lung cancer when 
exposed to acrylonitrile is increased. In this analysis, however, we have assumed that there is no 
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relationship between AN exposure and respiratory disease mortality which may not be an 
appropriate assumption. 
 
 
3.0    DISCUSSION 
 
3.1    COMPARISON OF FIRST AND SECOND METHOD 
 
In this thesis, we analyzed the impact of adjusting for confounding by smoking on the results of the 
AN exposure study by Marsh et al (1999) using two different methods, Monte Carlo simulation  of 
the smoking data and bias adjustment via Richardson’s method. These methods yielded disparate 
results. 
 
The results of the Monte Carlo simulation revealed what was expected, as we initially believed that 
smoking habits were positively confounding the RRs. It is well known that smoking is a major risk 
factor in lung cancer mortality. Thus, smoking should be an important potential confounder when 
analyzing a relationship between AN exposure and lung cancer. The smoking information in the 
original cohort was not consistent with this previously known association between smoking and 
lung cancer as the RR for lung cancer mortality given smoking history was 1.08. A Monte Carlo 
simulation allowed us to adjust the data to create a more realistic balance of ever/never smokers in 
the cohort. After running the simulation, we found that the mean RRs of lung cancer death given 
differing levels of AN exposure decreased after adjusting for the simulated smoking data. 
Moreover, a larger increase in smoking to lung cancer RRs was correlated with a larger drop in the 
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exposure vs. lung cancer RRs. In other words, the risk of dying from lung cancer due to exposure to 
acrylonitrile in the Lima cohort decreased slightly after accounting for positive confounding by 
smoking in the model. 
 
In Richardson’s method, possible confounding by smoking was removed by using Richardson’s 
method. Here, we removed the bias created by a relationship between AN exposure and smoking. 
Any association between AN exposure and deaths from COPD and heart disease represented a 
relationship between exposure and smoking history because the two causes are not associated with 
AN exposure. After running the computations using Richardson’s method, the RRs for lung cancer 
mortality given AN exposure changed very little. This method, then, suggests the association 
between lung cancer death and AN exposure is not confounded by smoking. In the original Lima 
cohort, removing the possible bias due to smoking did not change the risk of dying from lung 
cancer. However, this method was limited by the small number of observed deaths for lung cancer, 
COPD, and heart disease, and the proper implementation Richardson’s method was not possible. 
 
In the Monte Carlo simulation, we concluded that adjusting for confounding by smoking slightly 
decreases the apparent relationship between dying from lung cancer and exposure to acrylonitrile 
(even at the highest level of exposure), but in Richardson’s method suggested that confounding 
from smoking was not an issue in the original analysis. However, given this data set and the limited 
number of cases, the Monte Carlo method provides more meaningful results than the analysis using 
Richardson’s method.  
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3.2    LIMITATIONS AND STRENGTHS 
 
We conclude that the Monte Carlo simulation method was more meaningful compared to the 
Richardson method for analyzing the effect of confounding from smoking for this data set. In the 
Monte Carlo method, we were able to account for the small number of observed deaths by running 
many simulations and reassigning different smoking histories for the cases and controls. Also, this 
method is supported by Bayesian theory in that we assumed there was already a relationship 
between lung cancer and smoking history thereby incorporating a prior distribution within the 
analysis. When Steenland and Greenland compared the results of MC sensitivity analysis to 
Bayesian analysis, the results were “similar”. For example, they concluded that the “Monte Carlo 
sensitivity analysis, adjusting for possible confounding by smoking, led to an adjusted standardized 
mortality ratio of 1.43 (95% Monte Carlo limits: 1.15, 1.78). Bayesian results were similar (95% 
posterior limits: 1.13, 1.84).” These techniques are further addressed and supported in the paper by 
Steenland and Greenland (2004). 
 
One issue with the Monte Carlo method is the difficulties in displaying and interpreting the results 
of the simulations. We calculated 500 different RRs in the simulation, and the correct descriptive 
statistic must be chosen to aptly convey the appropriate relationship. Here, the mean was chosen, 
but the median or any of the 500 individual RRs may have been more appropriate for summarizing 
the results. Additionally, in any simulation, conclusions are not founded on observed results but 
rather on simulated data. Therefore any interpretation of the results depends on many assumptions 
made prior to the analysis. In our simulation, we addressed only the most extreme scenario of 
misclassification in which every lung cancer case except one was reassigned as a smoker. Finally, 
27 
the small data set and inadequate number of lung cancer deaths was an issue. This limited the level 
of simulation possible as there were only 15 cases to reassign. 
On the other hand, Richardson’s method is much easier to perform, especially if one is not familiar 
with simulations and the necessary coding. Additionally, the calculations are quick and easy to 
interpret. However, these seem to be the only advantages of the Richardson’s method when 
applying to our data example. Our analysis was limited, as above, by the small number of lung 
cancer cases in the original study, so we were unable to run the analysis as Richardson originally 
recommended. Additionally, there were very few cases of COPD death in the data set. This forced 
us to include other causes of death to model the association between smoking and AN exposure. 
These other health issues do not necessarily have the known correlation with smoking and the 
absence of a relationship with AN exposure. 
4.0 CONCLUSIONS 
In summary, the Monte Carlo method is more meaningful for analyzing a possible effect of 
confounding due to smoking in the Lima cohort. In this method, we concluded that smoking did 
indeed confound the relationship between AN exposure and lung cancer death. After adjusting for 
the well-known relationship between smoking and lung cancer and the observed relationship 
between AN exposure and smoking, the RRs for lung cancer death related to acrylonitrile exposure 
decreased in the Lima cohort, and we observed somewhat less evidence of a relationship between 
AN exposure and lung cancer. 
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APPENDIX A: Figure & Tables 
Figure 1: Comparison of Relative Risk Results using Simulated Lima, OH Cohort Data 
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Table 1: Original Lima, OH Cohort Data-- Lifetime Cigarette Smoking History by AN 
                    Exposure  a.  
 
a. Reported by Marsh et al. (1999)  
 
 
 
Table 2: Original Lima, OH Cohort Data—Summary of Relative Risk Regression Analysis 
(Univariate Models) for Lung Cancer Mortality a. 
 
Variable Category 
Observed 
Deaths 
RR (95% CI) 
Global Test      
p-value 
Smoking History 
Never 
Ever 
Unknown 
3 
10 
2 
1.00 
1.08 (0.26-6.18) 
1.18 (0.09-11.44) 
0.999 
Duration of AN 
Exposure 
Unexposed 
>0-4.9 
5.0-13.9 
14+ 
6 
3 
3 
3 
1.00 
1.71 (0.25-8.94) 
2.28 (0.35-11.38) 
2.15 (0.34-10.70) 
0.598 
Cumulative AN 
Exposure 
Unexposed 
>0-7.9 
8.0-109.9 
110+ 
6 
2 
4 
3 
1.00 
1.97 (0.18-12.04) 
2.15 (0.43-9.33) 
1.97 (0.31-9.42) 
0.645 
Average Intensity 
of AN Exposure 
Unexposed 
>0-4.9 
5.0-11.9 
12.0+ 
6 
3 
3 
3 
1.00 
1.97 (0.31-9.54) 
1.70 (0.26-8.26) 
2.64 (0.42-12.67) 
0.513 
a. All RRs are adjusted for age and calendar time via risk set matching
b. Reported by Marsh et al. (1999) 
AN_Cum 
(ppm-years) 
Number 
of Cases 
Ever Smoked Never Smoked Unknown 
Number 
of Obs. 
% of Total 
Cohort 
Number 
of Obs. 
% of Total 
Cohort 
Number 
of Obs. 
% of Total 
Cohort 
Unexposed 6 258 54.4 155 32.7 61 12.9 
Ever Exposed 9 280 54.0 203 39.2 35 6.8 
   >0-7.9 2 89 43.2 99 48.1 18 8.7 
   8.0-109.9 4 130 55.1 91 38.6 15 6.4 
   110+ 3 61 80.3 13 17.1 2 2.6 
TOTAL 15 538 54.2 358 36.1 96 9.7 
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Table 3: Original Lima, OH Cohort Data—Summary of Relative Risk Regression Analysis 
(Bivariate Models a.) for Lung Cancer Mortality b.c. 
 
Variable Category 
Observed 
Deaths 
RR (95% CI) 
Global Test      
p-value 
Duration of AN 
Exposure 
Unexposed 
>0-4.9 
5.0-13.9 
14+ 
6 
3 
3 
3 
1.00 
1.25 (0.17-7.03) 
1.82 (0.26-9.66) 
2.20 (0.34-11.24) 
0.713 
Cumulative AN 
Exposure 
Unexposed 
>0-7.9 
8.0-109.9 
110+ 
6 
2 
4 
3 
1.00 
1.27 (0.10-8.94) 
1.60 (0.29-7.57) 
2.19 (0.34-10.70) 
0.723 
Average Intensity 
of AN Exposure 
Unexposed 
>0-4.9 
5.0-11.9 
12.0+ 
6 
3 
3 
3 
1.00 
1.18 (0.16-6.84) 
1.46 (0.22-7.29) 
2.91 (0.46-14.13) 
0.514 
a. Models adjusted for time since first employment (< 20, 20-30, 30+) 
b. All RRs are adjusted for age and calendar time via risk set matching
c.  Report by Marsh et al. (1999)  
 
 
 
Table 4: Summary of Simulated External Odds Ratios using the Original Lima, OH Cohort  
Scenario 
Number of Cases 
Identified as 
“Ever Smoked” 
Number of Cases 
Identified as “Never 
Smoked” or 
“Unknown” 
Smoking 
Prevalence 
Among Cases 
Odds 
Ratio 
Fisher’s Exact  
P-Value 
Original 10 5 66.7% 0.985 1.00 
1 11 4 73.3% 1.355 0.417 
2 12 3 80.0% 1.971 0.408 
3 13 2 86.7% 3.202 0.164 
4 14 1 93.3% 6.898 0.028* 
      *Statistically significant at 0.05 level 
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Table 5: Original Lima, OH Cohort Data—Risk Set Details Used in Monte Carlo Simulations  
Case 
Number 
Number of 
Controls 
Ever Smoked 
Case, Control 
Never Smoked 
Case, Control 
Unknown 
Case, Control 
1 22 1, 3 0, 16 0, 3 
2 166 0, 40 1, 111 0, 15 
3 47 1, 14 0, 30 0, 3 
4 91 0, 22 1, 62 0, 7 
5 123 1, 27 0, 86 0, 10 
6 52 1, 13 0, 34 0, 5 
7 114 1, 27 0, 78 0, 9 
8 119 1, 30 0, 77 0, 12 
9 62 0, 15 1, 41 0, 6 
10 78 1, 20 0, 51 0, 7 
11 27 1, 5 0, 20 0, 2 
12 7 0, 0 0, 4 1, 3 
13 79 1, 21 0, 51 0, 7 
14 29 1, 7 0, 19 0, 3 
15 5 0, 1 0, 4 1, 0 
TOTAL 1,021 10, 245 3, 684 2, 92 
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Table 6: Summary of Conditional Logistic Regression Results using Simulated Lima, OH Cohort Data 
1  Reported by Marsh et al. (1999) 
2  Adjusted for time since first employment 
3  Simulated results are based on 500 models 
Model Original Univariate 1 Original Final Model  1,2 
Summary 
Statistics 
Smoking 
History 
RR Confidence Interval AN Exp RR Confidence Interval 
Never 
Ever 
1.00 
1.08 (0.28-6.18) 
Unexposed 
>0 - 4.9 
5.0 -11.9 
12.0 + 
1.00 
1.18 
1.46 
2.91 
(0.16-6.84) 
(0.22-7.29) 
(0.46-14.13) 
Model Scenario 4A 2,3 Scenario 4B 2,3 Scenario 4C 2,3 
Summary 
Statistics 
Category 
Mean 
RR 
Std. Dev (Min, Max) Category 
Mean 
RR 
Std. Dev (Min, Max) Category 
Mean 
RR 
Std. Dev (Min, Max) 
Smoking 
History 
Never 
Ever 
1.00 
1.48 0.43 (0.48, 2.96) 
Never 
Ever 
1.00 
2.48 0.47 (1.31, 4.34) 
Never 
Ever 
1.00 
2.92 0.40 (2.04, 4.37 
AN 
Exposure 
Unexposed 
>0 - 4.9 
5.0 -11.9 
12.0 + 
1.00 
1.17 
1.47 
2.99 
0.04 (0.97, 1.24) 
0.05 (1.27, 1.69) 
0.08 (2.80, 3.39) 
Unexposed 
>0 - 4.9 
5.0 -11.9 
12.0 + 
1.00 
1.12 
1.37 
2.75 
0.06 (0.87, 1.26) 
0.07 (1.12, 1.60) 
0.14 (2.44, 3.31) 
Unexposed 
>0 - 4.9 
5.0 -11.9 
12.0 + 
1.00 
1.07 
1.22 
2.52 
0.05 (0.91, 1.19) 
0.06 (0.99, 1.45) 
0.11 2.30, 2.88) 
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Table 7: Original Lima, OH Cohort Data— Summary of Bivariate Conditional Logistic 
Regression Results 
Table 8: Original Lima, OH Cohort Data—Summary of Univariate Conditional Logistic 
Regression Results 
Outcome Variable Number of Cases 
Independent 
Variable 
RR 
95% Confidence 
Interval 
Lung Cancer Death 15 
AN Exposure 
   Never 
   Ever 
1.00 
1.035 (0.97,1.11) 
Smoking History 
   Never 
   Ever 
   Unknown 
1.00 
1.10 
1.18 
(0.30, 4.05) 
(0.18, 7.73) 
Outcome Variable Number of Cases 
Independent 
Variable 
RR 
95% Confidence 
Interval 
Lung Cancer Death 15 
AN Exposure 
   Never 
   Ever 
1.00 
1.034 (0.96, 1.09) 
COPD/ Heart 
Disease Death 
13 
AN Exposure 
   Never 
   Ever 
1.00 
0.99 (0.97, 1.03) 
Respiratory 
Disease Deaths 
9 
AN Exposure 
   Never 
   Ever 
1.00 
0.80 (051, 1.26) 
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Table 9: Summary of Adjusted Estimated Relative Risks for Lung Cancer Mortality Using 
Richardson’s Method 
Bias Variable ln(RR1)-ln(RR2) 
Change 
in RR 
95% Confidence 
Interval 
COPD/HD Deaths 
(Relative Risk) 
1.035 0.0 (0.964, 1.106) 
COPD/HD Deaths 
(Lower Limit of 95% Confidence Interval) 
1.07 -0.035 (0.143, 1.497) 
COPD/HD Deaths 
(Upper Limit of 95% Confidence Interval) 
1.00 0.035 (0.88, 3.192) 
Respiratory Disease Deaths 
(Relative Risk) 
1.292 0.257 (0.136, 2.448) 
Respiratory Disease Deaths  
(Lower Limit of 95% Confidence Interval) 
2.03 -0.995 (0.668, 2.480) 
Respiratory Disease Deaths  
(Upper Limit of 95% Confidence Interval) 
0.82 0.215 (0.426, 1.238) 
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APPENDIX B: STATA Code 
Scenario 4A – Least Extreme 
program define neverTOever10 
drop smk smk1 smk01 _Ismk1_1 _Itsfe_2 _Itsfe_3 _Iaie_1 _Iaie_2 _Iaie_3
reshape wide  casecontrol aie tsfe, i(  recordnumber) j( casenumber) 
generate smk=ever_smk 
replace smk=rbinomial(1, 0.5) if smk==9 & ever_case==0  
generate smk1=1 if smk==1 
replace smk=0 if smk==9 
replace smk1=rbinomial(1, 0.67) if smk==0 & ever_case==0 & ever_3==1 
replace smk1=rbinomial(1, 0.67) if smk==0 & ever_case==0 & ever_2==1 
replace smk1=rbinomial(1, 0.67) if smk==0 & ever_case==0 & ever_1==1 
replace smk1=rbinomial(1, 0.67) if smk==0 & ever_case==0 & never==1 
reshape long 
sort  casecontrol aie tsfe 
drop in 1037/5850 
*gen smk01=rbinomial(1, 0.67) if smk==0 & ever_case==1
replace smk1=1 if smk1==. & casecon==0 
gen smk01= 1 if casecon==1 & smk==1 
sort caseco smk01 
replace smk01 = 1 in 1036 
replace smk01 = 1 in 1035 
replace smk01 = 1 in 1034 
replace smk01 = 1 in 1033 
replace smk01 = 0 in 1032 
replace smk1=smk01 if casecon==1 
*replace smk1=ever_smk if caseco==0 & ever_smk==0
xi:clog caseco i.smk1 , group(casenumber) or 
xi:clog caseco i.smk1 i.aie i.tsfe, group(casenumber) or 
end 
simulate _b _se, reps(100): neverTOever10 
program define neverTOever10 
drop smk smk1 smk01 _Ismk1_1 _Itsfe_2 _Itsfe_3 _Iaie_1 _Iaie_2 _Iaie_3
reshape wide  casecontrol aie tsfe, i(  recordnumber) j( casenumber) 
generate smk=ever_smk 
replace smk=rbinomial(1, 0.5) if smk==9 & ever_case==0  
generate smk1=1 if smk==1 
replace smk=0 if smk==9 
replace smk1=rbinomial(1, 0.67) if smk==0 & ever_case==0 & ever_3==1 
replace smk1=rbinomial(1, 0.67) if smk==0 & ever_case==0 & ever_2==1 
replace smk1=rbinomial(1, 0.67) if smk==0 & ever_case==0 & ever_1==1 
replace smk1=rbinomial(1, 0.67) if smk==0 & ever_case==0 & never==1 
reshape long 
sort  casecontrol aie tsfe 
drop in 1037/5850 
*gen smk01=rbinomial(1, 0.67) if smk==0 & ever_case==1
replace smk1=1 if smk1==. & casecon==0 
gen smk01= 1 if casecon==1 & smk==1 
sort caseco smk01 
replace smk01 = 1 in 1036 
replace smk01 = 1 in 1035 
replace smk01 = 1 in 1034 
replace smk01 = 0 in 1033 
replace smk01 = 1 in 1032 
replace smk1=smk01 if casecon==1 
*replace smk1=ever_smk if caseco==0 & ever_smk==0
xi:clog caseco i.smk1 , group(casenumber) or 
xi:clog caseco i.smk1 i.aie i.tsfe, group(casenumber) or 
end 
simulate _b _se, reps(100): neverTOever10 
program define neverTOever10 
drop smk smk1 smk01 _Ismk1_1 _Itsfe_2 _Itsfe_3 _Iaie_1 _Iaie_2 _Iaie_3
   36
reshape wide  casecontrol aie tsfe, i(  recordnumber) j( casenumber) 
generate smk=ever_smk 
replace smk=rbinomial(1, 0.5) if smk==9 & ever_case==0  
generate smk1=1 if smk==1 
replace smk=0 if smk==9 
replace smk1=rbinomial(1, 0.67) if smk==0 & ever_case==0 & ever_3==1 
replace smk1=rbinomial(1, 0.67) if smk==0 & ever_case==0 & ever_2==1 
replace smk1=rbinomial(1, 0.67) if smk==0 & ever_case==0 & ever_1==1 
replace smk1=rbinomial(1, 0.67) if smk==0 & ever_case==0 & never==1 
reshape long 
sort  casecontrol aie tsfe 
drop in 1037/5850 
*gen smk01=rbinomial(1, 0.67) if smk==0 & ever_case==1
replace smk1=1 if smk1==. & casecon==0 
gen smk01= 1 if casecon==1 & smk==1 
sort caseco smk01 
replace smk01 = 1 in 1036 
replace smk01 = 1 in 1035 
replace smk01 = 0 in 1034 
replace smk01 = 1 in 1033 
replace smk01 = 1 in 1032 
replace smk1=smk01 if casecon==1 
*replace smk1=ever_smk if caseco==0 & ever_smk==0
xi:clog caseco i.smk1 , group(casenumber) or 
xi:clog caseco i.smk1 i.aie i.tsfe, group(casenumber) or 
end 
simulate _b _se, reps(100): neverTOever10 
program define neverTOever10 
drop smk smk1 smk01 _Ismk1_1 _Itsfe_2 _Itsfe_3 _Iaie_1 _Iaie_2 _Iaie_3
reshape wide  casecontrol aie tsfe, i(  recordnumber) j( casenumber) 
generate smk=ever_smk 
replace smk=rbinomial(1, 0.5) if smk==9 & ever_case==0  
generate smk1=1 if smk==1 
replace smk=0 if smk==9 
replace smk1=rbinomial(1, 0.67) if smk==0 & ever_case==0 & ever_3==1 
replace smk1=rbinomial(1, 0.67) if smk==0 & ever_case==0 & ever_2==1 
replace smk1=rbinomial(1, 0.67) if smk==0 & ever_case==0 & ever_1==1 
replace smk1=rbinomial(1, 0.67) if smk==0 & ever_case==0 & never==1 
reshape long 
sort  casecontrol aie tsfe 
drop in 1037/5850 
*gen smk01=rbinomial(1, 0.67) if smk==0 & ever_case==1
replace smk1=1 if smk1==. & casecon==0 
gen smk01= 1 if casecon==1 & smk==1 
sort caseco smk01 
replace smk01 = 1 in 1036 
replace smk01 = 0 in 1035 
replace smk01 = 1 in 1034 
replace smk01 = 1 in 1033 
replace smk01 = 1 in 1032 
replace smk1=smk01 if casecon==1 
*replace smk1=ever_smk if caseco==0 & ever_smk==0
xi:clog caseco i.smk1 , group(casenumber) or 
xi:clog caseco i.smk1 i.aie i.tsfe, group(casenumber) or 
end 
simulate _b _se, reps(100): neverTOever10 
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Scenario 4B - Moderate 
program define neverTOever10 
drop smk smk1 smk01 _Ismk1_1 _Itsfe_2 _Itsfe_3 _Iaie_1 _Iaie_2 _Iaie_3
reshape wide  casecontrol aie tsfe, i(  recordnumber) j( casenumber) 
generate smk=ever_smk 
replace smk=rbinomial(1, 0.5) if smk==9 & ever_case==0  
generate smk1=1 if smk==1 
replace smk=0 if smk==9 
replace smk1=rbinomial(1, 0.8) if smk==0 & ever_case==0 & ever_3==1 
replace smk1=rbinomial(1, 0.7) if smk==0 & ever_case==0 & ever_2==1 
replace smk1=rbinomial(1, 0.3) if smk==0 & ever_case==0 & ever_1==1 
replace smk1=rbinomial(1, 0.3) if smk==0 & ever_case==0 & never==1 
reshape long 
sort  casecontrol aie tsfe 
drop in 1037/5850 
*gen smk01=rbinomial(1, 0.67) if smk==0 & ever_case==1
replace smk1=1 if smk1==. & casecon==0 
gen smk01= 1 if casecon==1 & smk==1 
sort caseco smk01 
replace smk01 = 1 in 1036 
replace smk01 = 1 in 1035 
replace smk01 = 1 in 1034 
replace smk01 = 1 in 1033 
replace smk01 = 0 in 1032 
replace smk1=smk01 if casecon==1 
*replace smk1=ever_smk if caseco==0 & ever_smk==0
xi:clog caseco i.smk1 , group(casenumber) or 
xi:clog caseco i.smk1 i.aie i.tsfe, group(casenumber) or 
end 
simulate _b _se, reps(100): neverTOever10 
program define neverTOever10 
drop smk smk1 smk01 _Ismk1_1 _Itsfe_2 _Itsfe_3 _Iaie_1 _Iaie_2 _Iaie_3
reshape wide  casecontrol aie tsfe, i(  recordnumber) j( casenumber) 
generate smk=ever_smk 
replace smk=rbinomial(1, 0.5) if smk==9 & ever_case==0  
generate smk1=1 if smk==1 
replace smk=0 if smk==9 
replace smk1=rbinomial(1, 0.8) if smk==0 & ever_case==0 & ever_3==1 
replace smk1=rbinomial(1, 0.7) if smk==0 & ever_case==0 & ever_2==1 
replace smk1=rbinomial(1, 0.3) if smk==0 & ever_case==0 & ever_1==1 
replace smk1=rbinomial(1, 0.3) if smk==0 & ever_case==0 & never==1 
reshape long 
sort  casecontrol aie tsfe 
drop in 1037/5850 
*gen smk01=rbinomial(1, 0.67) if smk==0 & ever_case==1
replace smk1=1 if smk1==. & casecon==0 
gen smk01= 1 if casecon==1 & smk==1 
sort caseco smk01 
replace smk01 = 1 in 1036 
replace smk01 = 1 in 1035 
replace smk01 = 1 in 1034 
replace smk01 = 0 in 1033 
replace smk01 = 1 in 1032 
replace smk1=smk01 if casecon==1 
*replace smk1=ever_smk if caseco==0 & ever_smk==0
xi:clog caseco i.smk1 , group(casenumber) or 
xi:clog caseco i.smk1 i.aie i.tsfe, group(casenumber) or 
end 
simulate _b _se, reps(100): neverTOever10 
program define neverTOever10 
drop smk smk1 smk01 _Ismk1_1 _Itsfe_2 _Itsfe_3 _Iaie_1 _Iaie_2 _Iaie_3
reshape wide  casecontrol aie tsfe, i(  recordnumber) j( casenumber) 
generate smk=ever_smk 
replace smk=rbinomial(1, 0.5) if smk==9 & ever_case==0  
generate smk1=1 if smk==1 
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replace smk=0 if smk==9 
replace smk1=rbinomial(1, 0.8) if smk==0 & ever_case==0 & ever_3==1 
replace smk1=rbinomial(1, 0.7) if smk==0 & ever_case==0 & ever_2==1 
replace smk1=rbinomial(1, 0.3) if smk==0 & ever_case==0 & ever_1==1 
replace smk1=rbinomial(1, 0.3) if smk==0 & ever_case==0 & never==1 
reshape long 
sort  casecontrol aie tsfe 
drop in 1037/5850 
*gen smk01=rbinomial(1, 0.67) if smk==0 & ever_case==1
replace smk1=1 if smk1==. & casecon==0 
gen smk01= 1 if casecon==1 & smk==1 
sort caseco smk01 
replace smk01 = 1 in 1036 
replace smk01 = 1 in 1035 
replace smk01 = 0 in 1034 
replace smk01 = 1 in 1033 
replace smk01 = 1 in 1032 
replace smk1=smk01 if casecon==1 
*replace smk1=ever_smk if caseco==0 & ever_smk==0
xi:clog caseco i.smk1 , group(casenumber) or 
xi:clog caseco i.smk1 i.aie i.tsfe, group(casenumber) or 
end 
simulate _b _se, reps(100): neverTOever10 
program define neverTOever10 
drop smk smk1 smk01 _Ismk1_1 _Itsfe_2 _Itsfe_3 _Iaie_1 _Iaie_2 _Iaie_3
reshape wide  casecontrol aie tsfe, i(  recordnumber) j( casenumber) 
generate smk=ever_smk 
replace smk=rbinomial(1, 0.5) if smk==9 & ever_case==0  
generate smk1=1 if smk==1 
replace smk=0 if smk==9 
replace smk1=rbinomial(1, 0.8) if smk==0 & ever_case==0 & ever_3==1 
replace smk1=rbinomial(1, 0.7) if smk==0 & ever_case==0 & ever_2==1 
replace smk1=rbinomial(1, 0.3) if smk==0 & ever_case==0 & ever_1==1 
replace smk1=rbinomial(1, 0.3) if smk==0 & ever_case==0 & never==1 
reshape long 
sort  casecontrol aie tsfe 
drop in 1037/5850 
*gen smk01=rbinomial(1, 0.67) if smk==0 & ever_case==1
replace smk1=1 if smk1==. & casecon==0 
gen smk01= 1 if casecon==1 & smk==1 
sort caseco smk01 
replace smk01 = 1 in 1036 
replace smk01 = 0 in 1035 
replace smk01 = 1 in 1034 
replace smk01 = 1 in 1033 
replace smk01 = 1 in 1032 
replace smk1=smk01 if casecon==1 
*replace smk1=ever_smk if caseco==0 & ever_smk==0
xi:clog caseco i.smk1 , group(casenumber) or 
xi:clog caseco i.smk1 i.aie i.tsfe, group(casenumber) or 
end 
simulate _b _se, reps(100): neverTOever10 
program define neverTOever10 
drop smk smk1 smk01 _Ismk1_1 _Itsfe_2 _Itsfe_3 _Iaie_1 _Iaie_2 _Iaie_3
reshape wide  casecontrol aie tsfe, i(  recordnumber) j( casenumber) 
generate smk=ever_smk 
replace smk=rbinomial(1, 0.5) if smk==9 & ever_case==0  
generate smk1=1 if smk==1 
replace smk=0 if smk==9 
replace smk1=rbinomial(1, 0.8) if smk==0 & ever_case==0 & ever_3==1 
replace smk1=rbinomial(1, 0.7) if smk==0 & ever_case==0 & ever_2==1 
replace smk1=rbinomial(1, 0.3) if smk==0 & ever_case==0 & ever_1==1 
replace smk1=rbinomial(1, 0.3) if smk==0 & ever_case==0 & never==1 
reshape long 
sort  casecontrol aie tsfe 
drop in 1037/5850 
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*gen smk01=rbinomial(1, 0.67) if smk==0 & ever_case==1
replace smk1=1 if smk1==. & casecon==0 
gen smk01= 1 if casecon==1 & smk==1 
sort caseco smk01 
replace smk01 = 0 in 1036 
replace smk01 = 1 in 1035 
replace smk01 = 1 in 1034 
replace smk01 = 1 in 1033 
replace smk01 = 1 in 1032 
replace smk1=smk01 if casecon==1 
*replace smk1=ever_smk if caseco==0 & ever_smk==0
xi:clog caseco i.smk1 , group(casenumber) or 
xi:clog caseco i.smk1 i.aie i.tsfe, group(casenumber) or 
end 
simulate _b _se, reps(100): neverTOever10 
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Scenario 4C – Most Extreme 
program define neverTOever10 
drop smk smk1 smk01 _Ismk1_1 _Itsfe_2 _Itsfe_3 _Iaie_1 _Iaie_2 _Iaie_3
reshape wide  casecontrol aie tsfe, i(  recordnumber) j( casenumber) 
generate smk=ever_smk 
replace smk=rbinomial(1, 0.5) if smk==9 & ever_case==0  
generate smk1=1 if smk==1 
replace smk=0 if smk==9 
replace smk1=rbinomial(1, 0.95) if smk==0 & ever_case==0 & ever_3==1 
replace smk1=rbinomial(1, 0.9) if smk==0 & ever_case==0 & ever_2==1 
replace smk1=rbinomial(1, 0.1) if smk==0 & ever_case==0 & ever_1==1 
replace smk1=rbinomial(1, 0.05) if smk==0 & ever_case==0 & never==1 
reshape long 
sort  casecontrol aie tsfe 
drop in 1037/5850 
*gen smk01=rbinomial(1, 0.67) if smk==0 & ever_case==1
replace smk1=1 if smk1==. & casecon==0 
gen smk01= 1 if casecon==1 & smk==1 
sort caseco smk01 
replace smk01 = 1 in 1036 
replace smk01 = 1 in 1035 
replace smk01 = 1 in 1034 
replace smk01 = 1 in 1033 
replace smk01 = 0 in 1032 
replace smk1=smk01 if casecon==1 
*replace smk1=ever_smk if caseco==0 & ever_smk==0
xi:clog caseco i.smk1 , group(casenumber) or 
xi:clog caseco i.smk1 i.aie i.tsfe, group(casenumber) or 
end 
simulate _b _se, reps(100): neverTOever10 
program define neverTOever10 
drop smk smk1 smk01 _Ismk1_1 _Itsfe_2 _Itsfe_3 _Iaie_1 _Iaie_2 _Iaie_3
reshape wide  casecontrol aie tsfe, i(  recordnumber) j( casenumber) 
generate smk=ever_smk 
replace smk=rbinomial(1, 0.5) if smk==9 & ever_case==0  
generate smk1=1 if smk==1 
replace smk=0 if smk==9 
replace smk1=rbinomial(1, 0.95) if smk==0 & ever_case==0 & ever_3==1 
replace smk1=rbinomial(1, 0.9) if smk==0 & ever_case==0 & ever_2==1 
replace smk1=rbinomial(1, 0.1) if smk==0 & ever_case==0 & ever_1==1 
replace smk1=rbinomial(1, 0.05) if smk==0 & ever_case==0 & never==1 
reshape long 
sort  casecontrol aie tsfe 
drop in 1037/5850 
*gen smk01=rbinomial(1, 0.67) if smk==0 & ever_case==1
replace smk1=1 if smk1==. & casecon==0 
gen smk01= 1 if casecon==1 & smk==1 
sort caseco smk01 
replace smk01 = 1 in 1036 
replace smk01 = 1 in 1035 
replace smk01 = 1 in 1034 
replace smk01 = 0 in 1033 
replace smk01 = 1 in 1032 
replace smk1=smk01 if casecon==1 
*replace smk1=ever_smk if caseco==0 & ever_smk==0
xi:clog caseco i.smk1 , group(casenumber) or 
xi:clog caseco i.smk1 i.aie i.tsfe, group(casenumber) or 
end 
simulate _b _se, reps(100): neverTOever10 
program define neverTOever10 
drop smk smk1 smk01 _Ismk1_1 _Itsfe_2 _Itsfe_3 _Iaie_1 _Iaie_2 _Iaie_3
reshape wide  casecontrol aie tsfe, i(  recordnumber) j( casenumber) 
generate smk=ever_smk 
replace smk=rbinomial(1, 0.5) if smk==9 & ever_case==0  
generate smk1=1 if smk==1 
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replace smk=0 if smk==9 
replace smk1=rbinomial(1, 0.95) if smk==0 & ever_case==0 & ever_3==1 
replace smk1=rbinomial(1, 0.9) if smk==0 & ever_case==0 & ever_2==1 
replace smk1=rbinomial(1, 0.1) if smk==0 & ever_case==0 & ever_1==1 
replace smk1=rbinomial(1, 0.05) if smk==0 & ever_case==0 & never==1 
reshape long 
sort  casecontrol aie tsfe 
drop in 1037/5850 
*gen smk01=rbinomial(1, 0.67) if smk==0 & ever_case==1
replace smk1=1 if smk1==. & casecon==0 
gen smk01= 1 if casecon==1 & smk==1 
sort caseco smk01 
replace smk01 = 1 in 1036 
replace smk01 = 1 in 1035 
replace smk01 = 0 in 1034 
replace smk01 = 1 in 1033 
replace smk01 = 1 in 1032 
replace smk1=smk01 if casecon==1 
*replace smk1=ever_smk if caseco==0 & ever_smk==0
xi:clog caseco i.smk1 , group(casenumber) or 
xi:clog caseco i.smk1 i.aie i.tsfe, group(casenumber) or 
end 
simulate _b _se, reps(100): neverTOever10 
program define neverTOever10 
drop smk smk1 smk01 _Ismk1_1 _Itsfe_2 _Itsfe_3 _Iaie_1 _Iaie_2 _Iaie_3
reshape wide  casecontrol aie tsfe, i(  recordnumber) j( casenumber) 
generate smk=ever_smk 
replace smk=rbinomial(1, 0.5) if smk==9 & ever_case==0  
generate smk1=1 if smk==1 
replace smk=0 if smk==9 
replace smk1=rbinomial(1, 0.95) if smk==0 & ever_case==0 & ever_3==1 
replace smk1=rbinomial(1, 0.9) if smk==0 & ever_case==0 & ever_2==1 
replace smk1=rbinomial(1, 0.1) if smk==0 & ever_case==0 & ever_1==1 
replace smk1=rbinomial(1, 0.05) if smk==0 & ever_case==0 & never==1 
reshape long 
sort  casecontrol aie tsfe 
drop in 1037/5850 
*gen smk01=rbinomial(1, 0.67) if smk==0 & ever_case==1
replace smk1=1 if smk1==. & casecon==0 
gen smk01= 1 if casecon==1 & smk==1 
sort caseco smk01 
replace smk01 = 1 in 1036 
replace smk01 = 0 in 1035 
replace smk01 = 1 in 1034 
replace smk01 = 1 in 1033 
replace smk01 = 1 in 1032 
replace smk1=smk01 if casecon==1 
*replace smk1=ever_smk if caseco==0 & ever_smk==0
xi:clog caseco i.smk1 , group(casenumber) or 
xi:clog caseco i.smk1 i.aie i.tsfe, group(casenumber) or 
end 
simulate _b _se, reps(100): neverTOever10 
program define neverTOever10 
drop smk smk1 smk01 _Ismk1_1 _Itsfe_2 _Itsfe_3 _Iaie_1 _Iaie_2 _Iaie_3
reshape wide  casecontrol aie tsfe, i(  recordnumber) j( casenumber) 
generate smk=ever_smk 
replace smk=rbinomial(1, 0.5) if smk==9 & ever_case==0  
generate smk1=1 if smk==1 
replace smk=0 if smk==9 
replace smk1=rbinomial(1, 0.95) if smk==0 & ever_case==0 & ever_3==1 
replace smk1=rbinomial(1, 0.9) if smk==0 & ever_case==0 & ever_2==1 
replace smk1=rbinomial(1, 0.1) if smk==0 & ever_case==0 & ever_1==1 
replace smk1=rbinomial(1, 0.05) if smk==0 & ever_case==0 & never==1 
reshape long 
sort  casecontrol aie tsfe 
drop in 1037/5850 
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*gen smk01=rbinomial(1, 0.67) if smk==0 & ever_case==1
replace smk1=1 if smk1==. & casecon==0 
gen smk01= 1 if casecon==1 & smk==1 
sort caseco smk01 
replace smk01 = 0 in 1036 
replace smk01 = 1 in 1035 
replace smk01 = 1 in 1034 
replace smk01 = 1 in 1033 
replace smk01 = 1 in 1032 
replace smk1=smk01 if casecon==1 
*replace smk1=ever_smk if caseco==0 & ever_smk==0
xi:clog caseco i.smk1 , group(casenumber) or 
xi:clog caseco i.smk1 i.aie i.tsfe, group(casenumber) or 
end 
simulate _b _se, reps(100): neverTOever10 
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